These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors. Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557 [TBL] [Abstract][Full Text] [Related]
26. Differential Diagnosis between Low-Grade and High-Grade Astrocytoma Using System A Amino Acid Transport PET Imaging with C-11-MeAIB: A Comparison Study with C-11-Methionine PET Imaging. Nishii R; Higashi T; Kagawa S; Arimoto M; Kishibe Y; Takahashi M; Yamada S; Saiki M; Arakawa Y; Yamauchi H; Okuyama C; Hojo M; Munemitsu T; Sawada M; Kobayashi M; Kawai K; Nagamachi S; Hirai T; Miyamoto S Contrast Media Mol Imaging; 2018; 2018():1292746. PubMed ID: 30026674 [TBL] [Abstract][Full Text] [Related]
27. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201 [TBL] [Abstract][Full Text] [Related]
31. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Kim S; Chung JK; Im SH; Jeong JM; Lee DS; Kim DG; Jung HW; Lee MC Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):52-9. PubMed ID: 15309332 [TBL] [Abstract][Full Text] [Related]
32. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016. Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675 [TBL] [Abstract][Full Text] [Related]
33. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329 [TBL] [Abstract][Full Text] [Related]
34. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI. Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531 [TBL] [Abstract][Full Text] [Related]
35. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166 [TBL] [Abstract][Full Text] [Related]
36. TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET. den Hollander MW; Bensch F; Glaudemans AW; Oude Munnink TH; Enting RH; den Dunnen WF; Heesters MA; Kruyt FA; Lub-de Hooge MN; Cees de Groot J; Pearlberg J; Gietema JA; de Vries EG; Walenkamp AM J Nucl Med; 2015 Sep; 56(9):1310-4. PubMed ID: 26135113 [TBL] [Abstract][Full Text] [Related]
37. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. Lopci E; Riva M; Olivari L; Raneri F; Soffietti R; Piccardo A; Bizzi A; Navarria P; Ascolese AM; Rudà R; Fernandes B; Pessina F; Grimaldi M; Simonelli M; Rossi M; Alfieri T; Zucali PA; Scorsetti M; Bello L; Chiti A Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1155-1164. PubMed ID: 28110346 [TBL] [Abstract][Full Text] [Related]
38. [Utility of 11C-methionine PET/CT in neuro-oncology]. Casas Parera I; Igirio Gamero JL; Blumenkrantz Y; Bruno G; Báez A; Tafur Canabal JG; Báez M; Kuchkaryan V Medicina (B Aires); 2013; 73(3):201-6. PubMed ID: 23732194 [TBL] [Abstract][Full Text] [Related]
39. Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Kracht LW; Friese M; Herholz K; Schroeder R; Bauer B; Jacobs A; Heiss WD Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):868-73. PubMed ID: 12692687 [TBL] [Abstract][Full Text] [Related]
40. Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging. Tietze A; Boldsen JK; Mouridsen K; Ribe L; Dyve S; Cortnum S; Østergaard L; Borghammer P Acta Radiol; 2015 Sep; 56(9):1135-44. PubMed ID: 25270372 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]